BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11584134)

  • 21. Small cysteine-rich peptides resembling antimicrobial peptides have been under-predicted in plants.
    Silverstein KA; Moskal WA; Wu HC; Underwood BA; Graham MA; Town CD; VandenBosch KA
    Plant J; 2007 Jul; 51(2):262-80. PubMed ID: 17565583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mode of action of membrane active antimicrobial peptides.
    Shai Y
    Biopolymers; 2002; 66(4):236-48. PubMed ID: 12491537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic challenges in the era of antibiotic resistance.
    Lee C
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S197-9. PubMed ID: 19134519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Peptides of eukaryotic origin with antimicrobial activity].
    López-Brea M; Alarcón T
    Rev Esp Quimioter; 1999 Dec; 12(4):300-9. PubMed ID: 10855008
    [No Abstract]   [Full Text] [Related]  

  • 25. Tigecycline: a new glycylcycline for treatment of serious infections.
    Noskin GA
    Clin Infect Dis; 2005 Sep; 41 Suppl 5():S303-14. PubMed ID: 16080069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gram-positive bacterial infections resistant to antibiotic treatment].
    Utili R
    Ann Ital Med Int; 2001; 16(4):205-19. PubMed ID: 11799629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The fight against bacteria: the antibiotics policy].
    Sztaricskai F
    Acta Pharm Hung; 2001; 71(1):89-98. PubMed ID: 11769102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides.
    Parisien A; Allain B; Zhang J; Mandeville R; Lan CQ
    J Appl Microbiol; 2008 Jan; 104(1):1-13. PubMed ID: 18171378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant production of antimicrobial peptides in heterologous microbial systems.
    Ingham AB; Moore RJ
    Biotechnol Appl Biochem; 2007 May; 47(Pt 1):1-9. PubMed ID: 17432953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection of antibiotic-resistant pathogens in the community.
    Yagupsky P
    Pediatr Infect Dis J; 2006 Oct; 25(10):974-6. PubMed ID: 17006309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic activity and synergistic effect of antimicrobial peptide against pathogens from a patient with gallstones.
    Park Y; Park SN; Park SC; Park JY; Park YH; Hahm JS; Hahm KS
    Biochem Biophys Res Commun; 2004 Aug; 321(3):631-7. PubMed ID: 15358153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of versatile plant antimicrobial peptides in agribusiness and human health.
    de Souza Cândido E; e Silva Cardoso MH; Sousa DA; Viana JC; de Oliveira-Júnior NG; Miranda V; Franco OL
    Peptides; 2014 May; 55():65-78. PubMed ID: 24548568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic resistance: how it arises, the current position and strategies for the future.
    Perry C; Hall C
    Nurs Times; 2009 Sep 15-21; 105(36):20-3. PubMed ID: 19835196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Selection of drugs in chemotherapy].
    Keller H
    Schweiz Med Wochenschr; 1975 Mar; 105(9):277-82. PubMed ID: 1124387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maggot microRNA: A new inhibitory pathway to bacterial infection.
    Wang S; Zhang Z
    Med Hypotheses; 2011 Feb; 76(2):254-5. PubMed ID: 21041037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial peptides: review of their application in musculoskeletal infections.
    Stallmann HP; Faber C; Nieuw Amerongen AV; Wuisman PI
    Injury; 2006 May; 37 Suppl 2():S34-40. PubMed ID: 16651070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular biology aspects of the antimicrobial effect of chemotherapeutic agents--antibiotics].
    Popov N
    Z Arztl Fortbild (Jena); 1982 Jul; 76(14):624-33. PubMed ID: 7180029
    [No Abstract]   [Full Text] [Related]  

  • 38. Bacterial resistance to antibiotics: enzymatic degradation and modification.
    Wright GD
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1451-70. PubMed ID: 15950313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chapter 2. From microbial products to novel drugs that target a multitude of disease indications.
    Marinelli F
    Methods Enzymol; 2009; 458():29-58. PubMed ID: 19374978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.